Article Versions Notes

Cunha S, Costa CP, Loureiro JA, Alves J, Peixoto AF, Forbes B, Sousa Lobo JM, Silva AC. Double Optimization of Rivastigmine-Loaded Nanostructured Lipid Carriers (NLC) for Nose-to-Brain Delivery Using the Quality by Design (QbD) Approach: Formulation Variables and Instrumental Parameters. Pharmaceutics. 2020; 12(7):599. https://doi.org/10.3390/pharmaceutics12070599

Cunha, Sara, Cláudia Pina Costa, Joana A. Loureiro, Jorge Alves, Andreia F. Peixoto, Ben Forbes, José Manuel Sousa Lobo, and Ana Catarina Silva. 2020. "Double Optimization of Rivastigmine-Loaded Nanostructured Lipid Carriers (NLC) for Nose-to-Brain Delivery Using the Quality by Design (QbD) Approach: Formulation Variables and Instrumental Parameters" Pharmaceutics 12, no. 7: 599. https://doi.org/10.3390/pharmaceutics12070599

Cunha, S., Costa, C. P., Loureiro, J. A., Alves, J., Peixoto, A. F., Forbes, B., Sousa Lobo, J. M., & Silva, A. C. (2020). Double Optimization of Rivastigmine-Loaded Nanostructured Lipid Carriers (NLC) for Nose-to-Brain Delivery Using the Quality by Design (QbD) Approach: Formulation Variables and Instrumental Parameters. Pharmaceutics, 12(7), 599. https://doi.org/10.3390/pharmaceutics12070599